Holiday notice: We will be off for the Chinese Lunar New Year Holiday between Feb 13th and 23th. Responses may be delayed. Welch US and India operate normally.
This application note presents a robust SEC-HPLC method for high-resolution aggregation analysis of a Pembrolizumab biosimilar using Welch Xtimate™ SEC-300 columns. The method demonstrates excellent separation of monomer, HMW aggregates, and LMW fragments, supporting routine QC and biosimilar comparability studies.